These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study. Rebora P, Czene K, Antolini L, Gambacorti Passerini C, Reilly M, Valsecchi MG. Am J Epidemiol; 2010 Nov 01; 172(9):1028-33. PubMed ID: 20861143 [Abstract] [Full Text] [Related]
9. The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States. Seymour EK, Ruterbusch JJ, Winn AN, George JA, Beebe-Dimmer JL, Schiffer CA. Cancer; 2021 Jan 01; 127(1):93-102. PubMed ID: 33119175 [Abstract] [Full Text] [Related]
13. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America. Karalexi MA, Baka M, Ryzhov A, Zborovskaya A, Dimitrova N, Zivkovic S, Eser S, Antunes L, Sekerija M, Zagar T, Bastos J, Demetriou A, Agius D, Florea M, Coza D, Polychronopoulou S, Stiakaki E, Moschovi M, Hatzipantelis E, Kourti M, Graphakos S, Pombo-de-Oliveira MS, Adami HO, Petridou ET. Eur J Cancer; 2016 Nov 01; 67():183-190. PubMed ID: 27677054 [Abstract] [Full Text] [Related]
17. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy. Mukhtar F, Ilozumba M, Utuama O, Cimenler O. JAMA Oncol; 2018 Jan 01; 4(1):48-53. PubMed ID: 28837714 [Abstract] [Full Text] [Related]
18. Changing pattern of secondary cancers among patients with malignant thymoma in the USA. Kumar V, Garg M, Goyal A, Chaudhary N, Soni P, Binod Chandra A. Future Oncol; 2018 Aug 01; 14(19):1943-1951. PubMed ID: 30081670 [Abstract] [Full Text] [Related]
19. Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a surveillance, epidemiology and end results (SEER) analysis. Wang Q, Jiang C, Zhang Y, Zhang Y, Yue B, Zheng-Lin B, Zhao Y, Mauro MJ. Leuk Lymphoma; 2020 May 01; 61(5):1147-1157. PubMed ID: 31985308 [Abstract] [Full Text] [Related]